Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 32

Trial Status

Completed1
Terminated3

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT04631211Phase 2Terminated
Thrombosomes® in Bleeding Thrombocytopenic Patients Study
Bone Marrow AplasiaHematologic MalignancyMyelodysplastic Syndromes+3 more
PrincipalinvestigatorStart date: 2021-03-05
NCT02578901Phase 3Completed
American Trial Using Tranexamic Acid in Thrombocytopenia
Thrombocytopenia
PrincipalinvestigatorStart date: 2016-06-01
NCT00991939Phase 3Terminated
Initial Treatment of Patients With Immune Thrombocytopenic Purpura
Immune Thrombocytopenic Purpura
Principalinvestigator

Research Network

Collaboration Network

36 collaborators·78 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mike Fitzpatrick, PhD

Cellphire Therapeutics, Inc.

Similar
1 trials

Shared therapeutic areas:

Bone Marrow AplasiaHematologic NeoplasmsMyelodysplastic Syndromes+3 more

Worked with same sponsors:

Cellphire Therapeutics, Inc.Department of Health and Human Services
Collaborated on 1 trial
Similarity Score64%

Joseph Kiss, MD

University of Pittsburgh

Related
3 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

David Kuter, MD

Massachusetts General Hospital

Related
5 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Ellis Neufeld, MD

Boston Children's Hospital

Related
6 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Judith Lin, MD

Brigham and Women's Hospital

Related
3 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Ann Zimrin, MD

University of Maryland

Related
2 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Cindy Leissinger, MD

Tulane University

Related
4 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, IdiopathicThrombocytopenia

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 2 trials
Similarity Score28%

Thomas Ortel, MD

Duke University

Related
4 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score14%

James Bussel, MD

Weill Medical College, Cornell University

Related
2 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score14%

Nigel Key, MD

University of North Carolina, Chapel Hill

Related
4 trials

Shared therapeutic areas:

Purpura, Thrombocytopenic, Idiopathic

Worked with same sponsors:

Carelon ResearchNational Heart, Lung, and Blood Institute (NHLBI)
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT04631211Phase 2PrincipalInvestigator

Thrombosomes® in Bleeding Thrombocytopenic Patients Study

Bone Marrow AplasiaHematologic MalignancyMyelodysplastic Syndromes+3 more
Terminated
NCT02578901Phase 3PrincipalInvestigator

American Trial Using Tranexamic Acid in Thrombocytopenia

Thrombocytopenia
Completed
NCT00594685PrincipalInvestigator

Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)

Thrombocytopenia
Terminated
NCT00991939Phase 3PrincipalInvestigator

Initial Treatment of Patients With Immune Thrombocytopenic Purpura

Immune Thrombocytopenic Purpura
Terminated

All 4 trials loaded